JP2022501031A5 - - Google Patents

Info

Publication number
JP2022501031A5
JP2022501031A5 JP2021515177A JP2021515177A JP2022501031A5 JP 2022501031 A5 JP2022501031 A5 JP 2022501031A5 JP 2021515177 A JP2021515177 A JP 2021515177A JP 2021515177 A JP2021515177 A JP 2021515177A JP 2022501031 A5 JP2022501031 A5 JP 2022501031A5
Authority
JP
Japan
Prior art keywords
car
cells
culture
modified immune
immune cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021515177A
Other languages
English (en)
Japanese (ja)
Other versions
JP7716976B2 (ja
JP2022501031A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/051832 external-priority patent/WO2020061256A1/en
Publication of JP2022501031A publication Critical patent/JP2022501031A/ja
Publication of JP2022501031A5 publication Critical patent/JP2022501031A5/ja
Priority to JP2025044165A priority Critical patent/JP2025106298A/ja
Application granted granted Critical
Publication of JP7716976B2 publication Critical patent/JP7716976B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021515177A 2018-09-19 2019-09-19 キメラ抗原受容体改変免疫細胞の活性化及び拡大培養のためのプロテインｌ Active JP7716976B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025044165A JP2025106298A (ja) 2018-09-19 2025-03-19 キメラ抗原受容体改変免疫細胞の活性化及び拡大培養のためのプロテインｌ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862733291P 2018-09-19 2018-09-19
US62/733,291 2018-09-19
PCT/US2019/051832 WO2020061256A1 (en) 2018-09-19 2019-09-19 Protein l for activation and expansion of chimeric antigen receptor-modified immune cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025044165A Division JP2025106298A (ja) 2018-09-19 2025-03-19 キメラ抗原受容体改変免疫細胞の活性化及び拡大培養のためのプロテインｌ

Publications (3)

Publication Number Publication Date
JP2022501031A JP2022501031A (ja) 2022-01-06
JP2022501031A5 true JP2022501031A5 (enExample) 2022-08-12
JP7716976B2 JP7716976B2 (ja) 2025-08-01

Family

ID=68085017

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021515177A Active JP7716976B2 (ja) 2018-09-19 2019-09-19 キメラ抗原受容体改変免疫細胞の活性化及び拡大培養のためのプロテインｌ
JP2025044165A Withdrawn JP2025106298A (ja) 2018-09-19 2025-03-19 キメラ抗原受容体改変免疫細胞の活性化及び拡大培養のためのプロテインｌ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025044165A Withdrawn JP2025106298A (ja) 2018-09-19 2025-03-19 キメラ抗原受容体改変免疫細胞の活性化及び拡大培養のためのプロテインｌ

Country Status (10)

Country Link
US (1) US12533414B2 (enExample)
EP (1) EP3853351A1 (enExample)
JP (2) JP7716976B2 (enExample)
KR (1) KR20210061397A (enExample)
CN (1) CN112739816B (enExample)
AU (1) AU2019345052B2 (enExample)
CA (1) CA3110706A1 (enExample)
IL (1) IL281413B2 (enExample)
SG (1) SG11202102654UA (enExample)
WO (1) WO2020061256A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4168537A1 (en) * 2020-06-17 2023-04-26 Tiziana Life Sciences PLC Compositions and methods for augmenting chimeric antigen receptor (car) t cell therapies
US20220333074A1 (en) 2021-04-07 2022-10-20 Century Therapeutics, Inc. Compositions and Methods for Generating Alpha-Beta T Cells from Induced Pluripotent Stem Cells
CA3214045A1 (en) 2021-04-07 2022-10-13 Century Therapeutics, Inc. Compositions and methods for generating gamma-delta t cells from induced pluripotent stem cells
JP7738826B2 (ja) * 2021-10-29 2025-09-16 東ソー株式会社 遺伝子改変ｔ細胞の製造方法
CN113980901B (zh) * 2021-12-28 2022-06-17 上海惠盾因泰生物科技有限公司 一种制备高纯度的成熟人树突状细胞的方法及应用
EP4717765A1 (en) * 2023-05-22 2026-04-01 Kyoto University Method for producing cell population containing cd4 single positive helper t cells from pluripotent stem cells

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL144339A0 (en) 1999-01-28 2002-05-23 Palmetto Health Alliance A cell line containing gamma delta lymphocytes and pharmaceutical compositions containing the same
US20030235908A1 (en) 2000-02-24 2003-12-25 Xcyte Therapies, Inc. Activation and expansion of cells
US7109304B2 (en) 2003-07-31 2006-09-19 Immunomedics, Inc. Humanized anti-CD19 antibodies
KR101408565B1 (ko) * 2005-09-30 2014-06-17 다카라 바이오 가부시키가이샤 Ｔ 세포 집단의 제조 방법
US20110158954A1 (en) * 2007-03-09 2011-06-30 Mitsuko Ideno Method for producing gamma delta t cell population
US20110027242A1 (en) 2008-03-27 2011-02-03 Takara Bio Inc. Method for production of transfected cell
CN102388130B (zh) 2009-02-27 2014-08-27 细胞动力国际有限公司 多能细胞的分化
KR20150004856A (ko) * 2012-04-20 2015-01-13 이머전트 프로덕트 디벨롭먼트 시애틀, 엘엘씨 Cd3 결합 폴리펩타이드
CN102816734A (zh) * 2012-05-09 2012-12-12 阮润生 一种肿瘤抗原特异性t细胞的获取方法
SG11201502598SA (en) 2012-10-02 2015-05-28 Sloan Kettering Inst Cancer Compositions and methods for immunotherapy
MX2017012939A (es) * 2015-04-08 2018-05-22 Novartis Ag Terapias cd20, terapias cd22 y terapias de combinacion con una celula que expresa un receptor quimerico de antigeno (car) de cd19.
EP3352571A1 (en) * 2015-09-25 2018-08-01 Flechsig Patent Company LLC Novel plant protecting compositions and uses thereof
ES2862676T3 (es) 2015-10-20 2021-10-07 Fujifilm Cellular Dynamics Inc Producción de células precursoras hematopoyéticas multilinaje mediante programación genética
MX2018005274A (es) 2015-10-30 2019-09-19 The Regents Of The Universtiy Of California Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t.
WO2017078807A1 (en) * 2015-11-04 2017-05-11 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
EP3370741B1 (en) 2015-11-04 2025-10-08 The Trustees of the University of Pennsylvania Methods and compositions for gene editing in hematopoietic stem cells
WO2017161092A1 (en) * 2016-03-16 2017-09-21 Neximmune, Inc. Production of antigen-specific t-cells
JP7685735B2 (ja) 2016-12-02 2025-05-30 アンヘレス セラピューティクス インコーポレイテッド 合成免疫受容体およびその使用方法
JPWO2021200901A1 (enExample) 2020-03-31 2021-10-07

Similar Documents

Publication Publication Date Title
MacDonald et al. Methods to manufacture regulatory T cells for cell therapy
US20230000919A1 (en) Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions
CN107922925B (zh) 用于自然杀伤细胞扩增的方法
US8071374B2 (en) Methods for preparing T-cells for cell therapy
Shimasaki et al. Expanded and armed natural killer cells for cancer treatment
Angoulvant et al. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens.
CN108473959B (zh) 用来在过继性免疫疗法中进行免疫细胞调节的组合物和方法
JP2020517237A5 (enExample)
CN107002039B (zh) 使用t细胞用于培养自然杀伤细胞的方法
Ye et al. Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes
JP2018515108A (ja) 準静的細胞培養
CN102428173A (zh) Nk细胞的扩增
JP6592551B2 (ja) 免疫調節活性を有する細胞集団、その調製方法、及び、その使用
US20210371820A1 (en) Method for amplifying antigen-specific regulatory t cells in vitro
CN115491354B (zh) 一种nk细胞分化的方法
Li et al. Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells
Good et al. Using human induced pluripotent stem cells for the generation of tumor antigen-specific T cells
US20040147021A1 (en) CD4+CD25 T cells and Tr1-like regulatory T cells
Smerchansky et al. Engineered multicellular niches for pluripotent stem cell–derived immunotherapy
JP2025502150A5 (enExample)
Maneechai et al. Generation of ex vivo autologous hematopoietic stem cell-derived T lymphocytes for cancer immunotherapy
CN102802686A (zh) 骨髓胞外基质提取物及其治疗用途
Williams et al. In vitro T lymphopoiesis: iPSCs for T cell generation, foundations, innovations, and future directions
Wilson et al. Stem Cell-Derived Cell Therapy for Cancer
Mehta et al. Ex vivo cord blood manipulation: Methods, data, and challenges